Esophageal Cancer: Tumor-Node-Metastasis Staging

Sonia L. Betancourt-Cuellar, Marcelo F.K. Benveniste, Diana P. Palacio, Wayne L. Hofstetter

Research output: Contribution to journalReview articlepeer-review

Abstract

Esophageal cancer is an uncommon malignancy that ranks sixth in terms of mortality worldwide. Squamous cell carcinoma is the predominant histologic subtype worldwide whereas adenocarcinoma represents the majority of cases in North America, Australia, and Europe. Esophageal cancer is staged using the American Joint Committee on Cancer and the International Union for Cancer Control TNM system and has separate classifications for the clinical, pathologic, and postneoadjuvant pathologic stage groups. The determination of clinical TNM is based on complementary imaging modalities, including esophagogastroduodenoscopy/endoscopic ultrasound; endoscopic ultrasound–fine-needle aspiration; computed tomography of the chest, abdomen, and pelvis; and fluorodeoxyglucose PET/computed tomography.

Original languageEnglish (US)
Pages (from-to)219-229
Number of pages11
JournalRadiologic Clinics of North America
Volume59
Issue number2
DOIs
StatePublished - Mar 2021
Externally publishedYes

Keywords

  • Computed tomography
  • Endoscopic ultrasound
  • Esophageal cancer
  • FDG positron emission tomography/computed tomography
  • TNM staging system

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Esophageal Cancer: Tumor-Node-Metastasis Staging'. Together they form a unique fingerprint.

Cite this